SIB 1508Y

CAS: 192231-16-6

Ref. 3D-SHA23116

Información del producto

• Nombre: SIB 1508Y
• Marca: Biosynth
• Descripción: SIB 1508Y is a prodrug that has been found to be effective in the treatment of Parkinson's disease. The drug is orally administered and converted to its active form, 6-methylene-5,6-dihydroxy-3-(4′-hydroxyphenyl)-2H-1,4-benzoxazin-2-one (SIB 1508), by esterases in the gastrointestinal tract. SIB 1508Y has been shown to inhibit tumor growth in animals. This drug also inhibits kinetics and hemodynamics of blood vessels.

Propiedades químicas

• Peso molecular: 302.32 g/mol
• Fórmula: C₁₆H₁₈N₂O₄
• Pureza: Min. 95%